Transcriptional changes mediated by the HDACi panobinostat in IDH-wildtype and IDH-mutant gliomas
RNA-seq (gene expression) · human · 54 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Lower-grade gliomaThis series is part of our curated briefing on it.
- Samples
- 54 samples: 14 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE308634_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1331756 and SRA study SRP622562. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 28 samples.
How we read this: 14 replicated groups read from 54 sample titles; they account for 28 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9249527 BT142_10nM_p12_rep1 BT142_10nM_p12
- GSM9249528 BT142_10nM_p12_rep2 BT142_10nM_p12
- GSM9249529 BT142_10nM_p15_rep3
- GSM9249530 BT142_Veh_p12_rep1 BT142_Veh_p12
- GSM9249531 BT142_Veh_p12_rep2 BT142_Veh_p12
- GSM9249532 BT142_Veh_p15_rep3
- GSM9249533 GBM12_10nM_8p2_rep1 GBM12_10nM_8p2
- GSM9249534 GBM12_10nM_8p2_rep2 GBM12_10nM_8p2
- GSM9249535 GBM12_10nM_8p7_rep3
- GSM9249536 GBM12_Veh_8p2_rep1 GBM12_Veh_8p2
- GSM9249537 GBM12_Veh_8p2_rep2 GBM12_Veh_8p2
- GSM9249538 GBM12_Veh_8p7_rep3
- GSM9249539 GBM43_10nM_7p4_rep1 GBM43_10nM_7p4
- GSM9249540 GBM43_10nM_7p4_rep2 GBM43_10nM_7p4
- GSM9249541 GBM43_10nM_8p6_rep3
- GSM9249542 GBM43_Veh_7p4_rep1 GBM43_Veh_7p4
- GSM9249543 GBM43_Veh_7p4_rep2 GBM43_Veh_7p4
- GSM9249544 GBM43_Veh_8p6_rep3
- GSM9249545 S0211_10nM_p10_rep1
- GSM9249546 S0211_10nM_p12_rep2
- GSM9249547 S0211_10nM_p9_rep3
- GSM9249548 S0211_Veh_p10_rep1
- GSM9249549 S0211_Veh_p12_rep2
- GSM9249550 S0211_Veh_p9_rep3
- GSM9249551 S0827_10nM_p10_rep1 S0827_10nM_p10
- GSM9249552 S0827_10nM_p10_rep2 S0827_10nM_p10
- GSM9249553 S0827_10nM_p9_rep3
- GSM9249554 S0827_Veh_p10_rep1 S0827_Veh_p10
- GSM9249555 S0827_Veh_p10_rep2 S0827_Veh_p10
- GSM9249556 S0827_Veh_p9_rep3
- GSM9249557 S0905_10nM_p13_rep1 S0905_10nM_p13
- GSM9249558 S0905_10nM_p13_rep2 S0905_10nM_p13
- GSM9249559 S0905_10nM_p8_rep3
- GSM9249560 S0905_Veh_p13_rep1 S0905_Veh_p13
- GSM9249561 S0905_Veh_p13_rep2 S0905_Veh_p13
- GSM9249562 S0905_Veh_p8_rep3
- GSM9249563 S0923_10nM_p8_rep1 S0923_10nM_p8
- GSM9249564 S0923_10nM_p8_rep2 S0923_10nM_p8
- GSM9249565 S0923_10nM_p9_rep3
- GSM9249566 S0923_Veh_p8_rep1 S0923_Veh_p8
+ 14 more — browse all 54 samples with per-sample file links →
- GSE308636 Transcriptional changes mediated by the HDACi belinostat in IDH-mutant glioma cultures with YAP and TAZ overexpression 36 samples same disease briefing · shares idh-mutant, mediated, changes, hdaci
- GSE308631 Changes in Histone H3 acetylation in panobinostat-treated IDH-wildtype and IDH-mutant glioma cultures 28 samples same disease briefing · shares panobinostat, idh-wildtype, idh-mutant, changes
- GSE326221 Acquired genetic and cell state changes in IDH-mutant glioma progression [snRNA-seq] 75 samples same disease briefing · shares idh-mutant, changes
- GSE252245 Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib 24 samples same disease briefing · shares idh-mutant, gliomas
- GSE89567 Single cell RNA-seq analysis of IDH-mutant astrocytoma 6341 samples same disease briefing · shares idh-mutant
- GSE260997 Mutant IDH inhibitors induce lineage differentiation in IDH-mutant Oligodendroglioma III 2458 samples same disease briefing · shares idh-mutant
- GSE226321 Multimodal integration of transcriptomics, proteomics and radiomics improves prediction of recurrence in patients with IDH-mutant Glioma 59 samples same disease briefing · shares idh-mutant
- GSE134120 Combination of epigenetic enzyme inhibitors, GSKJ4 and Belinostat, reveals efficacy in IDH1 mutant gliomas 16 samples same disease briefing · shares gliomas
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.